Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor’s Extracellular Hinge Region by Paul Grzesik et al.
September 2015 | Volume 6 | Article 1401
Original research
published: 22 September 2015
doi: 10.3389/fendo.2015.00140
Frontiers in Endocrinology | www.frontiersin.org
Edited by: 
Brian J. Arey, 
Bristol-Myers Squibb Co, USA
Reviewed by: 
Leigh Stoddart, 
University of Nottingham, UK 
Guillermo Romero, 
University of Pittsburgh, USA
*Correspondence:
Gerd Krause, 
Leibniz Institut für Molekulare 
Pharmakologie (FMP), 
Robert-Rössle-Strasse 10, 
Berlin 13125, Germany 
gkrause@fmp-berlin.de
Specialty section: 
This article was submitted to 
Molecular and Structural 
Endocrinology, a section of the 
journal Frontiers in Endocrinology
Received: 26 May 2015
Accepted: 24 August 2015
Published: 22 September 2015
Citation: 
Grzesik P, Kreuchwig A, Rutz C, 
Furkert J, Wiesner B, Schuelein R, 
Kleinau G, Gromoll J and Krause G 
(2015) Differences in signal activation 
by LH and hCG are mediated by the 
LH/CG receptor’s extracellular 
hinge region. 
Front. Endocrinol. 6:140. 
doi: 10.3389/fendo.2015.00140
Differences in signal activation 
by lh and hcg are mediated by the
lh/cg receptor’s extracellular 
hinge region
 
Paul Grzesik 1, Annika Kreuchwig 1, Claudia Rutz 1, Jens Furkert 1, Burkhard Wiesner 1,  
Ralf Schuelein 1, Gunnar Kleinau 2, Joerg Gromoll 3 and Gerd Krause 1*
1 Leibniz Institut für Molekulare Pharmakologie (FMP), Berlin, Germany, 2 Institute of Experimental Paediatric Endocrinology, 
Charité-Universitätsmedizin Berlin, Berlin, Germany, 3 Centre of Reproductive Medicine and Andrology, University Hospital 
Münster, Munich, Germany
The human lutropin (hLH)/choriogonadotropin (hCG) receptor (LHCGR) can be
activated by binding two slightly different gonadotropic glycoprotein hormones,
choriogonadotropin (CG)  –  secreted by the placenta, and lutropin (LH)  –  produced 
by the pituitary. They induce different signaling profiles at the LHCGR. This cannot 
be explained by binding to the receptor’s leucine-rich-repeat domain (LRRD), as this 
binding is similar for the two hormones. We therefore speculate that there are pre-
viously unknown differences in the hormone/receptor interaction at the extracellular 
hinge region, which might help to understand functional differences between the two 
hormones. We have therefore performed a detailed study of the binding and action of 
LH and CG at the LHCGR hinge region. We focused on a primate-specific additional 
exon in the hinge region, which is located between LRRD and the serpentine domain. 
The segment of the hinge region encoded by exon10 was previously reported to be 
only relevant to hLH signaling, as the exon10-deletion receptor exhibits decreased 
hLH signaling, but unchanged hCG signaling. We designed an advanced homology 
model of the hormone/LHCGR complex, followed by experimental characterization of 
relevant fragments in the hinge region. In addition, we examined predictions of a helical 
exon10-encoded conformation by block-wise polyalanine (helix supporting) mutations. 
These helix preserving modifications showed no effect on hormone-induced signaling. 
However, introduction of a structure-disturbing double-proline mutant LHCGR-Q303P/
E305P within the exon10-helix has, in contrast to exon10-deletion, no impact on hLH, 
but only on hCG signaling. This opposite effect on signaling by hLH and hCG can be 
explained by distinct sites of hormone interaction in the hinge region. In conclusion, our 
analysis provides details of the differences between hLH- and hCG-induced signaling 
that are mainly determined in the L2-beta loop of the hormones and in the hinge region 
of the receptor.
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introduction
The G protein-coupled receptors (GPCR) comprise a large super-
family of signal-mediating membrane bound proteins. The human 
lutropin (hLH)/choriogonadotropin (hCG) receptor (LHCGR) is 
evolutionary linked with the follitropin receptor (FSHR) and the 
thyrotropin receptor (TSHR). These three receptors belong to the 
group of glycoprotein-hormone receptors (GPHR), a subfamily 
of the rhodopsin-like GPCR (1). The structural topology of the 
GPHR is characterized by a large N-terminal extracellular region, 
which can be subdivided into the leucine-rich-repeat domain 
(LRRD) and the hinge region. The LRRD is responsible for the 
initial interaction with its corresponding hormone; the hinge 
region (LHCGR: L285-E354), harbors a second hormone binding 
site. It acts as a structural and functional link with the transmem-
brane region and thus assumes a key role in signal initiation and 
transduction (2). The transmembrane spanning region consists of 
seven transmembrane helices (TMH), connected by intra-cellular 
loops (ICLs) and extracellular loops (ECLs) and a cytoplasmic tail 
(Figure 1). Conformational changes in the TMH region during 
the activation lead to interaction and release of the intracellular 
signaling proteins (3).
In mammals, especially in primates, LHCGR has an essen-
tial role during male sexual differentiation and fertility. This is 
mainly mediated by the receptor-mediated signal transduction 
stimulating androgen biosynthesis, either in female theca or male 
Leydig cells. Lack of androgen biosynthesis due to impaired or 
inactivated LHCGR results in severe disturbances in male sexual 
differentiation (Leydig cell hypoplasia) or primary amenorrhea 
(4). An additional glycoprotein, choriogonadotropin (CG), is 
specific to primates. This is produced by the trophoblasts dur-
ing pregnancy and is required for androgen production in male 
fetuses. Thus, in human and (most) primates, we have a unique 
two hormone/one receptors system consisting of LH/CG and 
its cognate receptor the LHCGR. The two hormones are evolu-
tionary homologs, with LH being produced by the pituitary and 
CG secreted by the placenta/trophoblasts (4).
Both hormones are heterodimeric glycoproteins that consist 
of a common α-subunit but differ in a non-covalently associated 
specific β-subunit. These differences lead to the activation of 
different signaling pathways and finally to distinct physiological 
responses (5). Moreover, differences in G-protein activation of 
Gs and Gq (6) and in trans-activation and cis-activation have 
been reported for hCG and hLH (7), which suggest that the hinge 
region does not only participate in signal initiation, but also 
plays a key role in the differentiation of signal transduction at 
the level of receptor activation. Functional studies have focused 
on this issue and have uncovered sensitive sections within the 
hinge region that are responsible for LH- and CG-mediated 
function (8, 9).
The concept that the hinge region within the ectodomain of 
the GPHR may have a key role in their activation was initially 
developed decades ago for TSHR, FSHR (10, 11), and also for 
the LHCGR (12). Subsequent work on numerous mutations and 
studies on chimeric receptors [TSHR (13–16), on FSHR (17) 
and on LHCGR (17–20)] have identified several key residues in 
the respective hinge regions that are essential in conveying the 
activation signal. Although the sequence differs most between the 
GPHRs in the hinge region, these studies on chimeric receptors 
showed that the hinge region of TSHR can be replaced by that 
FigUre 1 | sketch (a) and homology model (B) of the full length lhcg-receptor with heterodimeric hormone (α and β subunit) bound to the 
extracellular leucine-rich-repeat domain (lrrD) and the hinge region. The hinge region that harbors exon10 and the second hormone binding site (sTyr) 
provides a structural and functional link between the LRRD and the heptahelical transmembrane domain.
FigUre 2 | Predicted structural segments for the middle part of the extracellular hinge region of lhcgr. For exon10, and the following residues, there is 
great sequence similarity to the crystal structural fragment of transferritin, which contains a helix. Four different methods I-TASSER [Cyan in (B)] (30, 31), Robetta 
[orange in (B)] (32), IntFold [magenta in (B)] (33), and RaptorX [blue in (B)] (34) predicted a common tertiary structure of the middle hinge region resulting in two helix 
segments, one for the exon10-region [orange cylinders in (a)] and for the following residues [gray cylinders in (a)]. Due to the consistent helix predictions by different 
methods and with the existing helix structure in homologous fragments, it is likely that this sequence contains a high propensity for an exon10-helix and an adjacent 
helix. The hormone binding sensitive sulfation site sTyr331 is located in an accessible coiled region.
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of FSHR (21) and LHCGR (10) while maintaining function to a 
certain extent, which indicates both a common topology, but also 
specificity, e.g., in the case of FSHR (22).
In this context, the naturally occurring deletion in LHCGR of 
the complete exon10-encoded segment (LHCGR-delExon10), 
corresponding to 27 amino acids (Figure 2A) within the hinge 
region of the hLHCGR, could be directly linked to a case of 
type 2 Leydig cell hypoplasia in which the natural hLH-, but 
not hCG-induced function was disturbed (8, 9). The resulting 
dysfunction in sexual puberty could be overcome by medica-
tion with hCG, but the observed functional differences in the 
exon10-deletion mutant have not yet been fully explained at the 
molecular level.
Further investigation on this receptor region uncovered a 
signaling-sensitive motif in close proximity to the exon10-region. 
A tyrosine rich-motif, located downstream of the exon10-region 
(Figure  2A), was proved to be crucial for hormone-induced 
receptor function. In vitro studies on the LHCGR showed that 
the sulfated tyrosine 331 (sTyr331) is essential for hLH triggering 
during receptor activation, but less sensitive toward hCG func-
tion (23). However, the complex structure–function relationship 
of the LHCGR and its hormones, in which LH and CG induce 
different signaling pathways upon receptor activation, is still 
unclear.
We postulated that specific structural determinants for 
the activation process lead to the differences in signaling. We 
aimed to shed light on the structure–function relationship of 
the LHCGR hinge region toward its hormones and gain in 
depth structural insights, by generating homology models of the 
interaction between the LHCGR hinge region with bound hLH 
and hCG hormones. In combination with functional data from 
mutagenesis studies within the exon10-region, our studies led us 
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to propose a molecular interaction model which is able to explain 
the complex situation in this hormone/receptor system during 
activation.
Materials and Methods
experimental setup
Construction of Vectors and Site-Directed 
Mutagenesis
The expression vector pEGFP-N1 (clontech) containing the 
fluorescent protein GFP as a C-terminal fusion partner was 
prepared for ligation by restriction with the restriction enzymes 
KpnI and BamHI. Amplicons of human receptor constructs 
wild-type LHCGR, hLHCGR-delExon10, and alanine-block 
constructs LHCGR-Ala1–6 were synthesized by standard PCR 
and overlapping extension-PCR, respectively, digested with 
corresponding restriction enzymes and sub-cloned into the 
backbone of vector pEGFP-N1. Site-directed mutagenesis of 
the LHCGR-wild type was performed by using the QuikChange 
Site-Directed Mutagenesis Kit (Stratagene), resulting in the pro-
line mutants LHCGR-Q303P/E308P and LHCGR-M320P. The 
entire coding region of each LHCGR construct was sequenced. 
Recombinant expression vectors were propagated using the 
DH5α E. coli strain.
Cell Culture and Transfection
LHCGR constructs were expressed as GFP fusion proteins in 
HEK 293 cells (DSMZ), by growing in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal calf 
serum (Biochrom) at 37°C in a humidified 5% CO2 incubator. 
HEK293 cells were seeded in 24-well plates and transfected with 
0.8 μg DNA/7.5 ×  104 cells. After 24  h of culture, one portion 
of the cells was prepared for FACS measurements, while the 
second portion was stimulated with the hormones hLH or hCG 
and prepared for the cAMP accumulation assay. For qualitative 
determination of cell surface expression, transfected cells were 
seeded in 24-well plates with 12 mm glass cover slips (pretreated 
with 100 μg/ml poly-l-lysine) and prepared in 12 mm diameter 
dishes for scanning microscopy. Transfection with PEI was car-
ried out according to the supplier’s recommendations 24 h after 
seeding the cells.
Determination of Overall Receptor Expression  
Levels by FACS
The overall expression levels of the GFP-tagged LHCGR con-
structs in singly transfected HEK 293 cells were quantified with 
a FACS flow cytometer (FACSCalibur; Becton-Dickinson). All 
steps were performed at 4°C. Twenty-four hours after seeding in 
24-well plates, cells were harvested by the use of 1 mM EDTA in 
PBS. After detachment, cells were centrifuged at 300 g for 3 min, 
and the supernatant was discarded. Cells were washed three times 
in FACS buffer (PBS containing 0.5% BSA), centrifuged (300 g 
for 3 min), and incubated for 5 min on ice. 7-Aminoactinomycin 
D (7-AAD) (Becton–Dickinson) was added to exclude damaged 
cells from analysis. The fluorescence of at least 10,000 cells per 
tube was assayed (FL1, 505–540 nm band pass filter). Expression 
of single expressed receptor constructs was determined from the 
mean fluorescence intensity. The overall receptor expression is 
presented as percentages of the corresponding singly expressed 
constructs compared with wild-type LHCGR, which is set as 
reference at 100%.
Confocal LSM: Localization and Quantification of the 
Receptor Constructs at the Plasma Membrane
Transiently transfected HEK 293 cells (1.5 × 105) expressing the 
receptors were grown on 30 mm glass cover slips (pretreated with 
100 μg/ml poly-l-lysine) in 35 mm dishes. After 24 h of culture, 
cover slips were transferred into a self-made chamber (details on 
request) and covered with 1ml DPBS(+)(+).
For colocalization studies, the GFP-tagged receptor constructs 
were visualized using the laser confocal scanning microscope 
LSM510 (Carl Zeiss Microscopy GmbH, Jena, Germany) with a 
100×/1.3 oil objective. The GFP-tagged constructs were detected 
in one channel (argon laser λexc = 488 nm, 495–545 nm band pass 
filter). Plasma membrane staining was performed with trypan 
blue, as previously described (24). The red fluorescence of trypan 
blue was recorded on a second channel (HeNe laser λexc = 543 nm, 
560  nm long pass) and the overlay with the GFP-signals was 
computed. The spectral ranges were split using an MBS 488/543. 
Images were analyzed using AIM software (release 3.2, Carl Zeiss 
Microscopy GmbH, Jena, Germany). Images were imported 
into PHOTOSHOP software (Adobe Systems), and contrast was 
adjusted to approximate the original image.
Quantification of the fluorescence intensity of the GFP-tagged 
constructs in the plasma membrane was carried out using the 
same microscope system. In this case, only one channel (green 
fluorescence, see above) was used. Images with frame sizes of 
512 × 512 pixels were generated and the ratio of receptor expres-
sion at the plasma membrane to that in intracellular membranes 
was calculated by measuring the fluorescence signal intensities of 
GFP in the selected regions of interest. The membrane/intracel-
lular ratio was calculated for each single cell after subtracting 
the background. At least 28 cells per construct were analyzed 
(Table 1).
Determination of Intracellular cAMP Accumulation  
by Radioimmunoassay
After transient transfection of HEK 293 cells, the functional 
properties of each LHCGR construct were tested by measuring the 
accumulated cAMP after stimulation with hLH and hCG in inde-
pendent experiments performed in triplicate. HEK 293 cells were 
seeded in 24-well plates, cultured for 24 h, and stimulated for 1 h at 
37°C with stimulation buffer (DMEM supplemented with 10 mM 
Hepes, 0.5% BSA, 0.25 mM 3-isobutyl-1-methylxanthine) alone, 
or with stimulation buffer containing increasing concentrations of 
hLH (14 000 IU/mg; Sigma-Aldrich) or hCG (5000 IU/mg; Merck 
4Biosciences). The experimental procedure of the cAMP radioim-
munoassay (RIA) was performed as previously described (25, 26).
Homology Models of LHCGR LRRD-Hinge Region 
With Bound Hormones LH and hCG
Structural homology models for the extracellular domains of 
LHCGR were built on the basis of the available FSHR crystal 
structures (27). The procedure for the homologous hTSHR 
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modeling has been already described in detail (28). Disulfide 
bridges between cysteines of cysteine boxes Cb-2 and Cb-3 
were built as suggested by the FSHR crystal structure. The 
sulfated sTyr335 of hFSHR was already known to be manda-
tory for hormone binding and signaling and interacts tightly 
with amino acids of the hormone subunits between the L2-beta 
loop and the L1-alpha loop (27). Both interaction models, 
hLHCGR/hLH and hLHCGR/hCG, were built (Figure 3). For 
the complex with bound hCG, hFSH in the template structure 
of the hFSH–hFSHR complex was substituted with the crystal 
structure of hCG [PDB-code: 1HRP, Ref. (29)]. In the hLH 
model, the alpha and beta-subunit of this hormone structure 
were used as template. Except for sequence 70PPLPQ74 that is 
different in the L2 loop of the beta-subunit, the corresponding 
fragment of another template 3TUV from PDB was used. On the 
basis of the N- and C-terminal fragments of the L2-beta loop 
of the crystal structures of CG (1QFW, 1HRP) and by overlap-
ping superimposition with the elongated conformation of the 
70PPLPQ74 fragment, the homology model of L2-beta loop was 
changed for hLH. Initially, side chains of the homology models 
were subjected to conjugate gradient minimizations [until they 
converged at a termination gradient of 0.05  kcal/(mol*Å)]. 
The AMBER F99 force field was used. Finally, the models were 
minimized without constraints. Structural modifications and 
homology modeling procedures were performed with Sybyl 
X2.0 (Certara, Inc., St. Louis, MI, USA).
Structure Predictions of Exon10
To build a three-dimensional model of the exon10-region as a 
part of the hinge region of LHCGR, we applied four different 
in silico web accessible methods for structure prediction:
We selected I-TASSER (30, 31), a de novo fold recognition 
method, the Robetta (32) protein structure and analysis server, 
TaBle 1 | expression of ec50 values and caMP-max values from caMP accumulation (a) and cell surface expression (B) of each lhcgr construct.
a. caMP accumulation B. cell surface expression
constructs lh stimulation cg stimulation
name ec50 (iU/ml) significance caMPmax ec50 [iU/ml] significance caMPmax Overall expression ratio sD N
(ci 95%) p < 0.05 % Wild type (ci 95%) p < 0.05 % Wild type % lhcgr-wild type Mem/intr
LHCGR-wild type 0.13 (0.08–0.18) 100 0.15 (0.03–0.27) 100 100 2.2 0.4 31
LHCGR-Ala1 0.25 (0.04–1.03) – 87 ± 11 0.13 (0.04–0.37) - 94 ± 11 89 ± 08 2.3 0.8 31
LHCGR-Ala2 0.28 (0.01–0.60) – 83 ± 12 0.04 (0.01–0.09) - 88 ± 12 104 ± 10 2.2 0.6 30
LHCGR-Ala3 0.11 (0.05–0.19) – 106 ± 10 0.05 (0.05–0.10) - 88 ± 16 105 ± 12 2.1 0.6 29
LHCGR-Ala4 0.13 (0.07–0.20) – 101 ± 08 0.06 (0.04–0.10) - 86 ± 16 104 ± 12 2.2 0.5 30
LHCGR-Ala5 0.13 (0.07–0.27) – 106 ± 11 0.08 (0.02–0.31) - 102 ± 10 94 ± 02 2.2 0.4 31
LHCGR-Ala6 0.19 (0.13–0.38) – 104 ± 07 0.13 (0.07–0.24) - 98 ± 08 98 ± 03 2.2 0.6 30
LHCGR-M320P 0.28 (0.18–0.43) – 98 ± 12 0.23 (0.13–0.41) - 99 ± 04 99 ± 04 2.2 0.6 28
LHCGR-Q303P/
E305P
0.24 (0.04–0.89) – 101 ± 10 0.85 (0.71–1.01) *** 98 ± 08 93 ± 03 2.2 0.6 30
LHCGR-delExon10 0.51 (0.13–0.89) ** 97 ± 08 0.18 (0.02–0.62) – 102 ± 10 89 ± 08 2.2 0.4 31
(A) EC50 and cAMP-max values were calculated from concentration-response curves (6 till 11 concentration values as duplicates or triplicates) of each construct and represent 
the mean (confidence interval CI 95%) from a representative experiment of at least two independent experiments. Within each single experimental run, the significance of the 
variance between the EC50 values and between the cAMP-max values of each LHCGR construct and LHCGR-wild type was tested in an ANOVA significance test. Significance 
is expressed as (–)-no significance, *significance (p < 0.05), **high significance (p < 0.005), ***very high significance (p < 0.001). (B) Relative cell surface receptor expression 
was calculated by combining FACS and membrane quantification data of single transfected cells. Calculated values are expressed as percentages of the corresponding singly 
expressed constructs tagged with GFP (FL1). Experiments were independently repeated at least three times, and data are shown ± SD. N, number of enumerated cells for 
membrane quantification.
IntFold2 (33), an integrated protein structure prediction pipeline 
based on fragment assembly and fold recognition, and finally 
RaptorX (34), which excels at modeling without using a large set 
of sequence homologs.
These differing prediction methods were chosen since they 
are the most successful modeling procedures in the “template 
free” category of the CASP7 experiment (35). All four methods 
build the initial protein models from short fragments of known 
structures with similar sequences. The predicted structures were 
visualized in Pymol (PyMOL, version 1.7.4 Schrödinger, LLC) 
(Figure 2B).
statistical analysis
For statistical analysis, PRISM Version 3.00 (GraphPad Software) 
was used. Concentration–response curves of the cAMP accumu-
lation data were obtained by utilizing a four-parameter logit-log 
model. Statistical significance was determined with one-way 
ANOVA (with Dunnett’s multiple comparison test as a post hoc 
test) or unpaired t-tests (with the Welch correction for cases with 
significant variance differences). We analyzed the key parameters 
of the whole dose–response curves (EC50 and maximal activity) 
within each experimental run (see legend of Table 1) considering 
the kind of parameter distribution (logarithmic normal distribu-
tion or Gaussian distribution).
results
First, we modeled the hormone receptor interactions, with 
consideration of (i) the differences between hLH and hCG and 
(ii) the potential structural conditions of the exon10-region of 
LHCGR. Second, we employed site-directed mutagenesis of 
exon10 in LHCGR to study the structure–function relationships 
of interaction of each hormone.
FigUre 3 | There are differences in the l2-beta loop for hlh and hcg. This gives rise to tighter binding for hLH than for hCG at sTyr331, the second binding 
site at LHCGR. (a) Homology model details of superimposed hormones hLH and hCG extracellularly bound to LRRD and hinge region of LHCGR based on the 
crystal structure of FSH/FSHR [4AY9, Ref. (9)]. (B) Sequence differences in L2-beta loop of these glycoprotein hormones (cjCG: New world monkey Callithrix 
jacchus). Gray: positions representing interacting elements of the sTyr moiety of the LHCGR hinge region. White on black background: differences in prolines 
between FSH and hLH, hCG, and even between hLH (red boxed) and hCG. (c) hLH was modeled based on the hCG structure (PDB: 1HRP, light green). Close up 
view: the L1-alpha loop is similar for hLH (dark blue) and hCG (cyan). The differing conformations of the L2-beta loop for hLH is based on a fragment in the crystal 
structure of Insulysin (3TUV) with identical sequence PPLPQ. The resulting backbone conformation of hLH (red) clearly differs from that in hCG structure (light green). 
The additional proline in hLH (see red box in B) restricts the conformational degree of freedom of βR63 (red) located in the N-terminal flank of the L2-beta loop. 
(D) Detailed view for hLH. The resulting binding cavity for sTyr331 formed by the L1-alpha loop (dark blue surface) and L2-beta loop (red surface) is more 
surrounded in hLH, and is flanked by the βR63 (red) and thus provides an additional H-bond donor for the interaction with the sTyr331 (yellow) of LHCGR compared 
to (e) detailed view for hCG (light green), where βR63 does not interact with sTyr331 and the binding pocket is much wider.
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structural Differences Derived From the 
homology Models of the complexes Between 
hcg/hlhcgr and hlh/hlhcgr With Focus on 
the sTyr Binding site
The binding mode of glycoprotein hormones (GPHs) at GPHRs 
was in principle determined by the crystal structures of the ecto-
domain of FSHR with bound FSH (9).
This structural complex confirmed previous assumptions of a 
primary (high affinity) and a secondary (low affinity) hormone 
binding site. The high affinity binding site at the LRRD has already 
been described in detail (36), but the structure of the low affin-
ity site around the sulfated tyrosine (sTyr) (37) has not yet been 
described for the LHCGR. This point is of specific importance, 
as it has already been shown experimentally that there must be 
differences between the receptor/hormone interactions at this site 
at LHCGR (20). We therefore first analyzed the differences in our 
designed homology models between the LHCGR/LH and LHCGR/
CG complexes in comparison to the FSHR/FSH structure (9).
The GPHs are heterodimers composed of a common alpha-subu-
nit and a variant beta-subunit. The binding site for the common sTyr 
motif of the GPHR’s hinge region (2) is formed by loops L1-alpha 
and L2-beta (Figure 3). The L1-alpha loop residues αN39 and αQ51 
of the common alpha-subunit are thus matching parts of the recep-
tors’ sTyr moiety that interact with all GPHs. However, in the L2-beta 
loop of the beta-subunit, there are a few but significant sequence 
differences between the GPHs. We therefore focus on the structural 
differences in the L2-beta loop in the different GPHs (Figure 3B), 
especially hLH and hCG, as well as their interactions with the 
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respective receptor. The N- and C-terminal flanks of the L2-beta loop 
exhibit some differences among the GPHs. The N-terminal flank of 
this loop provides interactions with negatively charged residue(s) of 
the respective receptor’s hinge region preceding the sTyr and with 
sTyr itself. For the different hormones, this is done by different 
residues in the relevant L2-beta loop. In FSH, the positively charged 
residue R53 and the hydrophobic residue L55 (Figure 3B) are the 
counterparts for the interaction with sTyr 335 (via water molecules) 
of the FSHR crystal structure (PDB: 4AY9, not shown).
Instead of an arginine (R53 in FSH) and leucine (L55 in FSH), 
the sequence of hLH and hCG exhibit at the corresponding posi-
tions: the hydrophobic M61 and the positively charged R63 at 
the N-terminal flank of the L2beta loop (Figure 3B). Thus, this 
opposite order of side chain properties lead to different spatial 
arrangements when hLH and hCG interact with sTyr331 of 
LHCGR, compared when FSH interacts with sTyr335 of FSHR.
Finally, these diverse molecular properties and interactions 
indicate that there are differences between FSHR and hLHCGR 
at this particular hormone/receptor interface.
In addition, the C-terminal flanking sequence of the L2beta 
loop differs between hLH and hCG with respect to specific and 
important prolines (Figure 3B). In contrast to hCG, hLH possesses 
two consecutive prolines (P70, P71). In order to model the different 
L2beta loop of hLH, a search for a structural template for the hLH 
motif 70PPLPQ revealed a fragment in the crystal structure of insuly-
sin (3TUV) with an identical sequence. This structural fragment 
was inserted into the L2beta loop of the hLH interaction model 
(red in Figures 3B–D) instead of the 70PALPQ sequence (green in 
Figures 3C,E of the hCG structure). In this homologous conforma-
tion, the side chain of the second proline P71 of hLH is oriented 
oppositely to A71 of hCG located in the corresponding position. The 
resulting L2-beta loop backbone conformation of our hLH interac-
tion model (red in Figures 3C,D) clearly differs from that in the 
crystal structures of hCG (green in Figures 3C,E). It is noticeable 
that this additional proline in our hLH interaction model is placed in 
a very similar orientation to the corresponding P63 in hFSH/FSHR 
crystal structure. However, due to the two consecutive prolines P70-
P71 in hLH (Figure 3B), this proline restricts the conformational 
degree of freedom of βR63 located in the N-terminal flank of the 
hLH L2-beta loop, instead of the L37 in hFSH (Figure 3B). As a 
consequence, the side chain of βR63 (red stick in Figure 3C, red 
surface in Figure 3D) is oriented toward the L1-alpha loop. This 
in turn results in hLH being in a more bordered binding cavity 
flanked by the βR63 and thus providing additional H-bond donors 
for the interaction with the sTyr331 (Figure 3D). This scenario is 
different in the analogous hCG interaction model, which lacks the 
second proline. Therefore βR63 (green in Figure 3C, green surface 
in Figure 3E) is not forced to orient toward L1-beta loop and does 
not participate in the interaction with sTyr331 (Figure 3E). In turn, 
hCG provides fewer H-bond donors than hLH for the interaction 
with sTyr331, the second hormone binding site of hLHCGR.
homology Models Predict a helical structure 
for the exon10-encoded hinge region of 
the lhcgr
Sequence-based secondary structure predictions suggest a helical 
secondary structure for the exon10-encoded region. An initial 
search for a structural template for the exon10-region of LHCGR 
by sequence similarity revealed a fragment of transferritin’s crystal 
structure (PDB entry 1BG7) with 54% sequence similarity to the 
exon10-encoded amio acid sequence. This structure showed an 
alpha-helical conformation (Figure 2A). For the residues next to 
the exon10-region, an additional helical structure of transferritin 
could be assigned.
Four different methods [I-TASSER (30, 31), Robetta (32), 
IntFOLD2 (33), and RAPTORX (34)] were applied for prediction 
of the tertiary structure of the exon10-region. All four methods 
agreed in predicting two helix segments for the exon10-region as 
well as for the following residues (Figures 2A,B).
Although not identical in every particular position, the four 
resulting models (Figure  2B) share at least similar topolo-
gies for the exon10-region and the following structural parts. 
Comparison of the applied approaches show that helix predic-
tions by different methods match with existing helix structures in 
homologous fragments. Therefore, it is likely that helical entities 
might exist within exon10 and within the directly following 
part of the hinge region of LHCGR prior to the sTyr moiety. 
Comparison of exon10 sequences of LHCGR among mamma-
lian species revealed a sequence similarity/IDENDITY pattern 
“QNfsfSIfeNFSkQCEST.Rkpnnel,” indicating that the identical 
residues (upper case) are matching with the conserved common 
region of the predicted helix.
The IntFold2 fragment matches the experimental data best. The 
initial homologous interaction model for the extracellular domain 
of LHCGR with bound hormones lacked the sequence in the 
middle of the hinge region, as this segment was unresolved in the 
crystal structure of FSH/FSHR (dashed orange line in Figure 3A). 
Thus, we inserted our predicted fragment for this missing part and 
generated an hLH/hLHCGR interaction model of the extracellular 
domain containing a complete hinge region for the first time. This 
resulted in an LHCGR/hLH interaction model, where  –  apart 
from the sTyr331 interaction with the binding pocket between 
alpha and beta-subunits of hLH (insert Figure 4) – the predicted 
exon10-helix and adjacent helix of LHCGR interact with the 
alpha-subunit of the hormone (zoomed in box, Figure 4).
Description of lhcgr Variants for Transient 
single expression and Functional 
characterization
To reveal the structure–function properties of the exon10-
encoded part of the LHCGR hinge region, an alanine-block 
scan was performed. Since polyalanine constructs are prone to 
form helix structures and helix formation was predicted, the 27 
exon10 amino acids (Q290-L316) were systematically substituted 
by five (LHCGR-Ala1–LHCGR-Ala3) and six (LHCGR-Ala4 and 
LHCGR-ALa5) alanines in a row. The predicted adjacent helix 
(construct LHCGR-Ala6) contains an alanine-block substitution 
of the amino acids 318–324 (Figure 5A). This region has been 
described as signaling sensitive (23). Since alanine blocks are 
capable of mimicking a helical structure (38), we introduced 
proline mutations which might disturb potential helical por-
tions, such as the double proline mutant at the position Q303P/
E305P. Additionally, in the wild-type LHCGR, position M320 was 
mutated to proline.
290 Exon10-Region 316   adjacent helix        331
LHCGR-wild type QNFSHSISENFSKQCESTVRKVSNKTLYSSMLAESELSGWDY
struc.elements ---HHHHHHHHHHHHHHHHHHHH------HHHHHH-------
LHCGR-Ala1 AAAAASISENFSKQCESTVRKVSNKTLYSSMLAESELSGWDY
LHCGR-Ala2 QNFSHAAAAAFSKQCESTVRKVSNKTLYSSMLAESELSGWDY
LHCGR-Ala3 QNFSHSISENAAAAAESTVRKVSNKTLYSSMLAESELSGWDY
LHCGR-Ala4 QNFSHSISENFSKQCAAAAAAVSNKTLYSSMLAESELSGWDY
LHCGR-Ala5 QNFSHSISENFSKQCESTVRKAAAAAAYSSMLAESELSGWDY
LHCGR-Ala6 QNFSHSISENFSKQCESTVRKVSNKTLYAAAAAAAELSGWDY
LHCGR-Q303P/E308P QNFSHSISENFSKPCPSTVRKVSNKTLYSSMLAESELSGWDY
LHCGR-M320P QNFSHSISENFSKQCESTVRKVSNKTLYSSPLAESELSGWDY
LHCGR-delEx10 ---------------------------YSSMLAESELSGWDY
A
FigUre 4 | extension of the hinge region in the homology model of the ectodomain of lhcgr with hlh bound to both the leucine-rich-repeat 
domain (lrrD) (wheat) and to this extension of the hinge region (lilac). The two predicted helices within the middle of hinge region, the exon10-helix (orange) 
and the adjacent helix (gray), interact with the alpha-subunit of hLH. The following sulfation group of sTyr331 (yellow) binds in a binding pocket between the 
alpha-subunit (blue) and beta-subunit (green) of hLH. The specific conformation of the hLH beta-subunit in the L2-beta loop caused by 70PPLP (colored in red) that 
differs from hCG (see also fig 2 colored in green) performs more productive H-bond interactions (insert upper right panel) than hCG.
FigUre 5 | continued
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The Occurrence of a helical structure 
Within exon10 is supported by results of 
Mutagenesis studies
FACS measurements revealed receptor expression of the LHCGR-
alanine-block constructs and the LHCGR-proline mutants, which 
was comparable to that of wild type (Table 1). The membrane/
intracellular ratio of expression of all the constructs was likewise 
similar to that of the wild type (Table 1). Analysis of confocal 
LSM (Figure 5B) confirmed plasma membrane expression of all 
LHCGR constructs.
The signaling properties of LHCGR-alanine-block mutants 
and proline mutants were then tested by cAMP accumulation 
assay. The EC50 and cAMP-max values were estimated from dose–
response curves of hLH and hCG stimulation. All of the LHCGR-
alanine-block mutants 1–6 (Figure  5) show stable cAMP-max 
values and also wild-type-like concentration-response curves 
with similar EC50 values for hLH and hCG stimulation (Table 1).
The LHCGR-delExon10 construct shows wild-type-like 
properties by stimulation with hCG [EC50 0.18 (0.02–0.62) 
IU/ml, Table  1; Figure  6A], however, a substantially right 
shifted concentration-response curve (Figure  6B) was 
observed for stimulation with hLH [EC50 0.51 (0.13–0.89) IU/
ml, Table 1]. This result indicates reduced receptor function with 
hLH and confirms previous observations (8, 9).
However, surprisingly the double proline LHCGR mutant 
Q303P/E305P substituted into exon10 gave exactly the opposite 
response to the deletion construct. The LHCGR-delExon10 con-
struct, lacking exon 10 entirely, affects hLH but not hCG-induced 
function. By contrast, the LH-induced function is not affected by 
LHCGR-Q303P/E305P [EC50 0.24 (0.04–0.89) IU/ml]. However, 
FigUre 5 | Mutations introduced in the middle of the lgcgr hinge region. (a) Sequence of LHCGR constructs of helix supporting block-wise polyalanine and 
directed helix-disturbing proline mutations within the exon10-helix and adjacent helix. (B) Localization of the GFP fluorescence signals of the LHCGR constructs in 
transiently transfected HEK 293 cells by confocal LSM. The GFP-signals of the fusions (left panel, green) and the Trypan blue signals of the membranes of the same 
cells (central panels, red) were computer-overlayed (right panels, yellow). GFP fluorescence is detectable only for transfected cells, whereas all cells show cell surface 
trypan blue fluorescence. All constructs are expressed on the plasma membrane surface.
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FigUre 6 | concentration-response curves differ for lh and hcg at 
lhcgr-wt and lhcgr-delexon10. It is shown that the mean of 
experimental values of two independent runs normalized on maximal activity. 
(a) Stimulation with hCG shows for the LHCGR-delExon10 construct (dark) 
LHCGR-wild-type (black) like properties; the helix-disturbing double proline 
LHCGR mutant Q303P/E305P substituted into exon10 (light) shows a 
right-shifted concentration-response curve. (B) By contrast, stimulation with 
hLH, shows a substantial right shift for the LHCGR-delExon10 construct 
(dark), whilst the function of the double proline LHCGR mutant Q303P/
E305P is nearly unaffected (light).
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the potency of hCG at this helix-disturbing construct is reduced, 
as is indicated by a right-shifted concentration-response curve 
with an increased EC50 value [EC50 0.85 (0.71–1.01) IU/ml, 
Table 1; Figure 6A]. It is striking that the single proline LHCGR 
mutant M320P shows no significant difference in comparison to 
the wild-type LHCGR for hLH and hCG stimulation (Table 1).
Discussion
The intramolecular activation mechanism at the extracellular side of 
LHCGR remains to be illuminated. Inspired by the crystal structure 
of the ectodomain of the FSHR/FSH complex (27), we recently 
described the specific hormone-hinge region interaction using a 
homology model of the TSH and TSHR complex (28). In this con-
text, we have utilized the crystal structure of the FSHR/FSH complex 
as a template to study structure–function relationships of hormone/
receptor interactions for LHCGR, with focus on the hinge region.
Thus, we initially built the first LHCGR model especially 
for the middle segment of the hinge region, not only since this 
section of 34 residues (I296-Y330) is not resolved in the FSHR 
structure (27), but also because molecular details of the interac-
tions between the respective hormone and the receptor’s hinge 
region evidently differ in this part of the LHCGR. The resulting 
LHCGR models share coincident spatial locations for LRRD 
and a pair of two cysteines from cysteine box 2 (Cb-2) and 3 
(Cb-3) which form cysteine bridges between Cys279–Cys343 and 
Cys280–Cys353 (Figures  1 and 8). This is consistent with the 
reported spatial proximity of Cb-2 and Cb-3, due to the disulfide 
bridges for LHCGR (23) and also for TSHR (39).
The hlh Binding site at a sulfated Tyrosine is 
Different From That of hcg
Apart from hormone binding to the LRRD, the sTyr331 of the 
hinge region is crucial for the second hormone binding site in 
LHCGR. According to the crystal structure of the FSHR/FSH 
(27), the sulfated group of sTyr interacts with a binding cavity 
formed by the loops L1-alpha and L2-beta in the hormone.
In our bound hLH model, a sequence difference between hLH 
and hCG in the L2-beta loop, with a proline P71 in hLH, instead 
of an alanine in hCG, causes a different backbone conformation in 
the L2-beta loop, from that in hCG. Therefore, the orientation of 
βR63 in bound hLH in our LHCGR–hLH interaction model has 
a much greater tendency to interact with the oxygen atom in the 
sulfated group of sTyr331 in the hinge region of LHCGR than with 
bound hCG (Figure 3). Moreover, in our models for the sTyr bind-
ing pocket, βR63 of hLH functions as an additional interaction 
partner for sTyr331 (βR63: red in Figure 3D) that is not present in 
hCG (βR63: green in Figure 3E). This is in good agreement with 
previous experimental data (20), in which the LHCGR mutation 
of Tyr331 to Ala leads to a greater decrease in potency for hLH, by 
more than 2300-fold relative to CG. Therefore, our LHCGR inter-
action models differ between LH and CG and provide a plausible 
explanation as to why hLH binds more tightly to the sTyr binding 
site of LHCGR hinge region than does hCG. Other discrepancies 
between hLH and hCG have been described previously (40).
Moreover, it is also very likely that hCG binds slightly differ-
ently than hLH to the LRRD of LHCGR, due to the additional 
C-terminal tail of the hCG beta-subunit. In that case, the loops 
L1-alpha and L2-beta, and thus also the sTyr binding pocket 
of bound hCG, might be placed closer to the hinge region and 
cause less or different movement of the hinge region prior to helix 
determined by exon10 and in comparison to bound hLH.
In a broader context and with reference to the in vivo situation, 
it might be interesting to note, that in the aforementioned patient 
who suffered from a homozygous exon 10 deletion, LH signaling 
is severely hampered, while hCG action is seemingly normal (9). 
This observation corroborates our functional studies in this man-
uscript. Moreover, studies by others on the LHCG-receptor have 
revealed that, in New world primates, LHCGR naturally lacks exon 
10, due to an aberrant splicing event. As a consequence thereof, 
the interacting hormone system has dramatically changed, with 
completely inactivated LH expression and activated CG system in 
the pituitary. This only can be explained by a selective interaction 
of the LHCGR lacking exon 10 with CG, but not LH (4).
The lhcgr exon 10 Determined region 
and adjacent Parts are Probably in helical 
structure-conformations
For homology modeling of the middle hinge region, including 
exon 10, for LHCGR, we selected four different servers, namely 
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IntFold2, RaptorX, I-TASSER, and Robetta, because in competi-
tion they have proven to be successful methods in predicting fold 
and tertiary structures of medium sized proteins or domains (35). 
As regards their prediction of secondary structural elements, all 
four different approaches coincidently suggest the topology of 
two helical structural entities in exon10 and in the region fol-
lowing shortly after. As regards the tertiary structure predictions, 
the two helices of the four models overlap, but are not exactly 
identical (Figure 2B).
We analyzed this critically by incorporating all four predicted 
structures into the hinge region and selected the IntFOLD2 
prediction that best fit the available data (Figure 4). We regarded 
these cautiously as rough estimates, since the regions – especially 
before exon 10 and after sTyr – might be conformationally flex-
ible. This has already been suggested for the corresponding region 
in the TSHR, where in the hormone-unbound state the region 
prior to sTyr might come close to the agonistic unit proximal to 
Cys-box 2 and 3 located at the pivotal helix of the hinge (28) (see 
Figure 8). Complementary charge distributions on the C-terminal 
end of the LRRD and on the sTyr moiety have been discussed 
for TSHR/FSHR chimeras (22). This supported the view that 
negative charges of the Asp-sTyr-Glu motif might interact with 
particular positive charges located in the LHCGR at LRRD repeat 
10 (R247) and on the pivotal helix of Cb-3 (e.g., R283) and on beta 
strand-12 (K339, R342; see residues, mutations and models also 
at our GPHR information resource: www.SSFA-GPHR.de (41)).
This hypothesis is consistent with the results reported for an 
activating antibody 13B1 of the hinge region of LHCGR (42), 
which interacts via a discontinuous sequence epitope comprising 
the N-terminal end of the exon10-region (Cb-2: 291–298), at 
Cb-3 with the signaling-sensitive tyrosine region (30–33), and 
two further residues (37, 39). It seems feasible that these three 
discontinuous sequence regions will be assembled close together 
as a fully accessible patch on the surface of the hinge region. 
Since this is the case in three of the four models of the exon 10 
fragments (Figure S1 in Supplementary Material), it suggests that 
the hinge region model of LHCGR matches most of the known 
experimental data and might be considered in the future for 
further refinement by experimental validations.
helix supporting and Disturbing Mutations 
confirm suggested structural elements
Since polyalanines are thought to form helical structure [54] and 
to test whether particular amino acids and/or the helical character 
of exon10 are responsible for full activation of LHCGR by hLH, we 
introduced block-wise polyalanine mutants in the exon10-region 
and into the predicted adjacent helical-region (Figure 5). Each 
alanine-block construct showed wild-type behavior in terms of 
signaling properties, characterized by cAMPmax and EC50 values 
(Table 1).
Importantly, the presented polyalanine scan also revealed 
that there is no specific influence of a particular amino acid and 
side-chain in the studied region, but supports the predicted two 
potential helical portions, one in exon10 and a second in the 
proximate following region (Figure 2).
To validate the conclusion that there are two structural 
elements, we next substituted, in contrast to helix supporting 
mutations, prolines into the predicted helical portions of exon10 
(Q303P, E305P) and into the adjacent helix (M320P), in order 
to disturb potential helical structures. The substituted prolines 
in exon10 gave completely opposite results for hLH- and hCG-
induced function than had been found for deletion of exon 10 in 
LHCGR. While in the construct, which lacks exon 10, only hLH 
signaling is affected, the construct with two prolines introduced 
into exon10-helix showed a significant negative effect on signal-
ing only for hCG.
FigUre 7 | sketches of the different hlh and hcg interactions with the middle section of the hinge region with various lhcgr constructs. 
(a) LHCGR-wt: exon10-helix shifts the sulfated sTyr331 into an appropriate spatial position necessary to interact with hLH, while, for hCG, exon10-helix acts as a 
structural interface. (B) LHCGR-delExon10: deletion of exon 10 leads to displacement of the remaining residues beyond the cutting point (red triangle). 
Subsequently sTyr331 abrogates the interaction with hLH, However, the adjacent helix moves into the position previously occupied by the exon 10-helix and thus 
provides a structural interface for activation by hCG; (c) LHCGR-Q303P/E308P double proline mutation within exon10 disturbs the helical structure of exon10-helix 
and interferes with the hCG-induced hinge movement and signaling. However, in this case, the retained length of the middle hinge region allows the appropriate 
adjustment of sTyr331 for proper hLH interaction and signaling.
FigUre 8 | Differences between hlh bound homology models of lhcgr hinge region and lhcgr hinge-delexon10. For LHCGR, the sulfated sTyr 
(yellow) of the hinge region (lilac) fits deep into the binding pocket of bound hLH between alpha- (surface blue) and beta-subunit (green, red adapted conformation 
for 70PPLP). For clarity, exon10-helix (orange) of LHCGR is cut open and the adjacent helix is omitted (dotted line). By contrast, the deletion in LHCGR-delExon10 
(pale pink) causes displacement of the residues in the middle of the hinge region after the deletion position (red triangle). Subsequently sTyr331 is displaced and thus 
the interaction of the sulfation group with the hLH binding pocket is impaired. However, the deletion of 27 residues in LHCGR-delEx10 (contains exon10-helix) 
causes the polypeptide chain to contract, so that the adjacent helix (gray) is arranged in the same place as the exon10-helix (orange). Upon hormone binding, the 
signal is conveyed via the hinge region (lilac) through a hormone-induced movement of the pivot helix, the disulfide linked agonistic unit and the area prior to the 
exon10-helix, both of which are probably embedded (dashed box) in between the loops of the transmembrane domain of LHCGR.
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These data suggest that the exon10-region serves for the two 
hormones in a different manner. For hLH-induced receptor 
activation, the exon10-helix is necessary as a non-specific spacer-
element to adjust the sulfated Tyr331 into an appropriate location 
and orientation for a compatible H-Bond interaction with hLH. 
For hCG-induced activation, the exon10 determined helix acts 
as a structural interface within the hinge region (Figure  7A). 
Deletion of exon 10 causes shortening of the middle hinge loop, 
which subsequently leads to spatial delocalization of the down-
stream regions. The sequence forming the adjacent helix comes 
into the position of the previous exon10-helix (Figures 7B and 
8). This might explain why hCG can induce signaling, probably 
because the displaced adjacent helix adopts the structural func-
tion of exon10-helix.
The delocalization also leads to displacement of the sulfate 
group of sTyr331, which is then unable to form H-bond inter-
actions with hLH (Figures  7B and 8). This explains why the 
LHCGR-del Exon10 construct affects hLH signaling much more 
strongly, since sulfated Tyr331 is not absolutely essential for 
hCG-induced function, in contrast to the case with hLH. In the 
case of the double proline mutation within exon10, the helical 
structure of exon10-helix is disturbed (Figure 7C); this interferes 
with the correct interaction of the hinge region with hCG and in 
consequence cAMP signaling is impaired. However, the length 
of the loop in the middle of the hinge region is retained, which 
still allows appropriate adjustment of sulfated Tyr331 for proper 
hLH interaction.
From these data, we conclude that LHCGR activation in 
the hinge region by hLH mainly depends on the distance from 
a specific amino acid (hormone in relation to sTyr331), while 
LHCGR function with hCG is closely related to an interaction 
with a structural element within the hinge region.
To summarize, by studying the activation mechanism of 
LHCGR using a naturally occurring pathogenic LHCGR-variant 
with reduced hLH function, we were able to pinpoint a sequence 
difference in the beta2 loop of hLH and hCG and assign two 
different structural features in the exon 10 determined region 
that are together probably responsible for the different modes 
of action of the hormones hLH and hCG within the receptor 
activation process. The exon10 part acts, on the one hand, as 
a non-specific spacer element that adjusts the sensitive residue 
sTyr331 to the appropriate position for triggering the hormone 
hLH. On the other hand, it functions as a structural interface 
for hCG-induced function. This implies that the two hormones 
interact differently with the hinge region. We conclude from pre-
vious work (27, 28) and our study here that the flexible part of the 
hinge region allows movement of the middle hinge region. In the 
hormone-free state, the hinge is arrested, probably by interac-
tions between pivot helix (Cb-2 linked Cb-3) and sTyr vicinity, 
since both areas comprise positions of activating mutations in 
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